SCILEX Pharmaceuticals Announces Appointments of Internationally Recognized Industry Experts
(Original source PR Newswire)
“MALVERN, Pa., June 8, 2015 /PRNewswire/ — SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced two appointments: Dr. Sanjay Gupta, a renowned physician with pain management expertise, to its Scientific Advisory Board; and Dr. Philip Gerbino, an award-winning global pharmaceutical consultant, as a Strategic Advisor.
These appointments further strengthen SCILEX’s proprietary drug development program, which includes ZTlido™ (lidocaine patch 1.8%) a next-generation patch being developed for the treatment of postherpetic neuralgia, or after-shingles pain.”
Click here to read more